235 related articles for article (PubMed ID: 24449363)
21. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.
Li W; Yue W; Zhang L; Zhao X; Ma L; Yang X; Zhang C; Wang Y; Gu M
Lung; 2012 Feb; 190(1):91-8. PubMed ID: 22109568
[TBL] [Abstract][Full Text] [Related]
22. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
Hidaka A; Sasazuki S; Matsuo K; Ito H; Charvat H; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Tsugane S;
Int J Cancer; 2016 Aug; 139(4):759-68. PubMed ID: 27062139
[TBL] [Abstract][Full Text] [Related]
23. [Genetic polymorphism of CYP-1A1, CYP2D6 and risks of chronic benzene poisoning].
Gu SY; Zhang ZB; Cao DZ; Wan JX; Gao XL; Jin XP; Xia ZL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):266-9. PubMed ID: 16737584
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
25. Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR.
McKeown-Eyssen G; Baines C; Cole DE; Riley N; Tyndale RF; Marshall L; Jazmaji V
Int J Epidemiol; 2004 Oct; 33(5):971-8. PubMed ID: 15256524
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.
Luo YP; Chen HC; Khan MA; Chen FZ; Wan XX; Tan B; Ou-Yang FD; Zhang DZ
Tumour Biol; 2011 Feb; 32(1):215-22. PubMed ID: 20878561
[TBL] [Abstract][Full Text] [Related]
27. CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.
Gutman G; Morad T; Peleg B; Peretz C; Bar-Am A; Safra T; Grisaru D
Int J Gynecol Cancer; 2009 Nov; 19(8):1300-2. PubMed ID: 20009880
[TBL] [Abstract][Full Text] [Related]
28. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
[TBL] [Abstract][Full Text] [Related]
31. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.
Demokan S; Suoglu Y; Gözeler M; Demir D; Dalay N
Mol Biol Rep; 2010 Oct; 37(7):3217-26. PubMed ID: 19898993
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in CYP1A1, CYP2D6, UGT1A6, UGT1A7, and SULT1A1 genes and correlation with benzene exposure in a Chinese occupational population.
Gu SY; Zhang ZB; Wan JX; Jin XP; Xia ZL
J Toxicol Environ Health A; 2007 Jun; 70(11):916-24. PubMed ID: 17479406
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk.
Cury NM; Russo A; Galbiatti AL; Ruiz MT; Raposo LS; Maniglia JV; Pavarino EC; Goloni-Bertollo EM
Mol Biol Rep; 2012 Feb; 39(2):1055-63. PubMed ID: 21590276
[TBL] [Abstract][Full Text] [Related]
34. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
[TBL] [Abstract][Full Text] [Related]
35. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers.
Reszka E; Czekaj P; Adamska J; Wasowicz W
Clin Chem Lab Med; 2008; 46(8):1090-6. PubMed ID: 18590468
[TBL] [Abstract][Full Text] [Related]
36. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
37. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.
Krajinovic M; Ghadirian P; Richer C; Sinnett H; Gandini S; Perret C; Lacroix A; Labuda D; Sinnett D
Int J Cancer; 2001 Apr; 92(2):220-5. PubMed ID: 11291049
[TBL] [Abstract][Full Text] [Related]
38. Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?
Gronau S; Koenig-Greger D; Jerg M; Riechelmann H
Otolaryngol Head Neck Surg; 2003 May; 128(5):674-80. PubMed ID: 12748560
[TBL] [Abstract][Full Text] [Related]
39. CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.
Lourenço GJ; Silva EF; Rinck-Junior JA; Chone CT; Lima CS
Tumour Biol; 2011 Dec; 32(6):1209-15. PubMed ID: 21870186
[TBL] [Abstract][Full Text] [Related]
40. Single-nucleotide polymorphisms in nucleotide excision repair genes, cigarette smoking, and the risk of head and neck cancer.
Wyss AB; Herring AH; Avery CL; Weissler MC; Bensen JT; Barnholtz-Sloan JS; Funkhouser WK; Olshan AF
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1428-45. PubMed ID: 23720401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]